Dr. Dejan Budimirovic, MD

Claim this profile

Kennedy Krieger Institute

Studies Fragile X Syndrome
4 reported clinical trials
8 drugs studied

Area of expertise

1

Fragile X Syndrome

Dejan Budimirovic, MD has run 4 trials for Fragile X Syndrome. Some of their research focus areas include:

FMR1 positive
FMR1

Affiliated Hospitals

Image of trial facility.

Kennedy Krieger Institute

Image of trial facility.

Kennedy Krieger

More about Dejan Budimirovic, MD

Clinical Trial Related

3 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 0 Active Clinical Trials

Treatments Dejan Budimirovic, MD has experience with

  • Placebo
  • Gaboxadol (HLX-0206)
  • Sulindac (HLX-0201)
  • BPN14770/ Zatolmilast
  • BPN14770
  • Zatolmilast

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Dejan Budimirovic, MD specialize in?

Is Dejan Budimirovic, MD currently recruiting for clinical trials?

Are there any treatments that Dejan Budimirovic, MD has studied deeply?

What is the best way to schedule an appointment with Dejan Budimirovic, MD?

What is the office address of Dejan Budimirovic, MD?

Is there any support for travel costs?